Molecular imaging in Parkinson's Disease


Cristina Polito.
Elektronisk ressurs Italiensk 2011
Omfang
1 online resource (68 pages) : : illustrations; digital, PDF file(s).
Opplysninger
The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients by means of molecular imaging techniques. Thirty-one consecutive drug-naïve PD patients from the Neurological Clinic of the University of Florence underwent clinical assessment, neuropsychological assessment, MRI, [123I]FP-CIT SPECT, [18F]FDG PET. First, [18F]FDG-PET was employed to identify in drug-naïve PD patients brain metabolic alteration uniquely related to disease process and not modulated by anti-parkinsonian therapeutic intervention. Second, [18F]FDG-PET and [123I]FP-CIT SPECT were employed together to explore the early functional changes in brain function related to dopaminergic depletion in the putamen and in the caudate nucleus.
Emner
Dewey
ISBN
9788866550419
ISBN(galt)

Bibliotek som har denne